These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23436479)

  • 1. Utilizing NMR and EPR spectroscopy to probe the role of copper in prion diseases.
    Emwas AH; Al-Talla ZA; Guo X; Al-Ghamdi S; Al-Masri HT
    Magn Reson Chem; 2013 May; 51(5):255-68. PubMed ID: 23436479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational conversion of prion protein in prion diseases.
    Zhou Z; Xiao G
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion disease: A loss of antioxidant function?
    Wong BS; Pan T; Liu T; Li R; Petersen RB; Jones IM; Gambetti P; Brown DR; Sy MS
    Biochem Biophys Res Commun; 2000 Aug; 275(2):249-52. PubMed ID: 10964653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using NMR spectroscopy to investigate the role played by copper in prion diseases.
    Alsiary RA; Alghrably M; Saoudi A; Al-Ghamdi S; Jaremko L; Jaremko M; Emwas AH
    Neurol Sci; 2020 Sep; 41(9):2389-2406. PubMed ID: 32328835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Yin-Yang role for metals in prion disease.
    Wong BS; Brown DR; Sy MS
    Panminerva Med; 2001 Dec; 43(4):283-7. PubMed ID: 11677424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The configuration of the Cu(2+) binding region in full-length human prion protein compared with the isolated octapeptide.
    Weiss A; Del Pino P; Bertsch U; Renner C; Mentler M; Grantner K; Moroder L; Kretzschmar HA; Parak FG
    Vet Microbiol; 2007 Aug; 123(4):358-66. PubMed ID: 17482774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metal binding on solubility and resistance of physiological prions depend on tissues and glycotypes.
    Kuczius T; Kelsch R
    J Cell Biochem; 2013 Dec; 114(12):2690-8. PubMed ID: 23794222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
    Havsteen BH
    J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of copper in prion diseases: deleterious or beneficial?
    Varela-Nallar L; González A; Inestrosa NC
    Curr Pharm Des; 2006; 12(20):2587-95. PubMed ID: 16842180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper and the prion protein: methods, structures, function, and disease.
    Millhauser GL
    Annu Rev Phys Chem; 2007; 58():299-320. PubMed ID: 17076634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role for Ca2+ in the pathophysiology of the prion protein?
    Peggion C; Bertoli A; Sorgato MC
    Biofactors; 2011; 37(3):241-9. PubMed ID: 21698700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5.
    Redecke L; Meyer-Klaucke W; Koker M; Clos J; Georgieva D; Genov N; Echner H; Kalbacher H; Perbandt M; Bredehorst R; Voelter W; Betzel C
    J Biol Chem; 2005 Apr; 280(14):13987-92. PubMed ID: 15684434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA molecules stimulate prion protein conversion.
    Deleault NR; Lucassen RW; Supattapone S
    Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of prion transmission].
    Sakaguchi S
    Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site.
    D'Angelo P; Della Longa S; Arcovito A; Mancini G; Zitolo A; Chillemi G; Giachin G; Legname G; Benetti F
    Biochemistry; 2012 Aug; 51(31):6068-79. PubMed ID: 22788868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein selectively binds copper(II) ions.
    Stöckel J; Safar J; Wallace AC; Cohen FE; Prusiner SB
    Biochemistry; 1998 May; 37(20):7185-93. PubMed ID: 9585530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of RNA in mammalian prion protein conversion.
    Gomes MP; Vieira TC; Cordeiro Y; Silva JL
    Wiley Interdiscip Rev RNA; 2012; 3(3):415-28. PubMed ID: 22095764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.